Blogs
Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.

diabetes

Knowing that you are interested in diabetes, we have listed articles on similar topics on the website for your convenience. As a professional manufacturer, we hope that this news can help you. If you are interested in learning more about the product, please feel free to contact us.
  • Market Expansion: Dapagliflozin Receives FDA Approval for Treating Type 2 Diabetes in Children

    Market Expansion: Dapagliflozin Receives FDA Approval for Treating Type 2 Diabetes in Children

    2024-06-13

    AstraZeneca has announced on June 12, 2024, that Farxiga (dapagliflozin) has been approved by the U.S. Food and Drug Administration (FDA) for improving glycemic control in children aged 10 years and above with type 2 diabetes (T2D). The FDA approval is based on the positive results from the Phase 3 Read More
  • The Growing Global Burden of Diabetes

    The Growing Global Burden of Diabetes

    2023-11-13

    November 14th marks World Diabetes Day, a day to raise awareness of the impact of diabetes globally. This year's theme is "Access to Diabetes", focusing on the importance of knowing your risk for type 2 diabetes and ensuring access to proper information and care. In honor of World Diabetes Day 2023, Read More